Nanwei Medical announced that the company and its wholly-owned subsidiary Nanjing Maichuang participated in the national organization's centralized procurement declaration for medical consumables, and various products will be selected. Among them, the company plans to select 21 types of single products and 2 sets of surgical kits, and 20 types of products will enter the A bidding unit; 5 products from Nanjing Maichuang will be selected, all belonging to the B bidding unit. The current collection and procurement cycle starts from the actual implementation date of the selection results in each region of the alliance until December 31, 2029. If a procurement agreement is successfully signed and implemented, it will help increase the coverage and market influence of domestic public medical institutions for the company's digestion of interventional products. The short-term decline in product terminal prices after collection and implementation will put some pressure on the gross margin of related products, and sales are expected to increase. Currently, the proposed selection results are still in the publicity stage, and there is uncertainty about the final selection results, the signing of the agreement, and actual implementation.

Nanwei Medical announced that the company and its wholly-owned subsidiary Nanjing Maichuang participated in the national organization's centralized procurement declaration for medical consumables, and various products will be selected. Among them, the company plans to select 21 types of single products and 2 sets of surgical kits, and 20 types of products will enter the A bidding unit; 5 products from Nanjing Maichuang will be selected, all belonging to the B bidding unit. The current collection and procurement cycle starts from the actual implementation date of the selection results in each region of the alliance until December 31, 2029. If a procurement agreement is successfully signed and implemented, it will help increase the coverage and market influence of domestic public medical institutions for the company's digestion of interventional products. The short-term decline in product terminal prices after collection and implementation will put some pressure on the gross margin of related products, and sales are expected to increase. Currently, the proposed selection results are still in the publicity stage, and there is uncertainty about the final selection results, the signing of the agreement, and actual implementation.